Supply of Lactated Ringer’s Injection (Medical Fluids)

The contract pertains to the manufacture and supply of Lactated Ringer’s Injection, USP, in 1000mL volumes, packaged in cases of twelve units, with strict adherence to United States Pharmacopeia standards and all applicable federal packaging regulations. The product is intended for medical use and must meet the highest quality and safety benchmarks required for intravenous fluid administration. Performance of the contract is designated for Bogalusa, Louisiana, with a zip code of 70427-0000, indicating the primary location for delivery or fulfillment. The solicitation is classified as a subcontract under NAICS code 325412, which corresponds to pharmaceutical and medicine manufacturing, and is administered by the Department of Defense through the Medical Supply Chain Pharm FSA. The posting date is July 28, 2026, with a response deadline of August 3, 2026, allowing potential suppliers a brief window to submit proposals. All submissions must comply with the technical and regulatory requirements specified by the agency to ensure suitability for federal medical use.